These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 143667)

  • 21. [Does the presence of HLA-B5 and B35 antigen signify a worse prognosis for Hodgkin's disease? Preliminary report].
    Prazák J; Hermanská Z
    Vnitr Lek; 1988 Mar; 34(3):270-6. PubMed ID: 3259347
    [No Abstract]   [Full Text] [Related]  

  • 22. Helper and cytotoxic T cell precursor frequencies are not predictive for development of acute graft-versus-host disease after partially T cell-depleted HLA-identical sibling BMT.
    van der Meer A; Allebes WA; Voorter CE; van den Berg-Loonen EM; Schattenberg AV; de Witte TJ; Joosten I
    Bone Marrow Transplant; 1998 Dec; 22(11):1049-55. PubMed ID: 9877266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etiological heterogeneity in Hodgkin's disease: HLA linked and unlinked determinants of susceptibility independent of histological concordance.
    Chakravarti A; Halloran SL; Bale SJ; Tucker MA
    Genet Epidemiol; 1986; 3(6):407-15. PubMed ID: 3803911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of HLA compatibility and lymphocyte cross-matching on acute cellular rejection following living donor adult liver transplantation.
    Suehiro T; Shimada M; Kishikawa K; Shimura T; Soejima Y; Yoshizumi T; Hashimoto K; Mochida Y; Maehara Y; Kuwano H
    Liver Int; 2005 Dec; 25(6):1182-8. PubMed ID: 16343070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA antigens in patients with adrenocortical hyperfunction.
    Lada G; Gyódi E; Gláz E
    Acta Med Acad Sci Hung; 1977; 34(4):213-26. PubMed ID: 618054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MLC compatibility, HLA-D and DR typing in cadaver kidney transplantations.
    Thomsen M; Morling N; Ladefoged J; Løkkegård H; Jakobsen B; Svejgaard A; Thaysen JH
    Scand J Urol Nephrol Suppl; 1980; 54():32-5. PubMed ID: 6452681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppressor cells of the mixed lymphocyte reaction in patients with Hodgkin's disease.
    Engleman EG; Benike C; Hoppe RT; Kaplan HS
    Transplant Proc; 1979 Dec; 11(4):1827-9. PubMed ID: 161096
    [No Abstract]   [Full Text] [Related]  

  • 28. HLA and insulin-dependent juvenile diabetes mellitus.
    Májský A; Dvoráková L
    Czech Med; 1983; 6(3):152-8. PubMed ID: 6416792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.
    Smits JM; Vanhaecke J; Haverich A; de Vries E; Smith M; Rutgrink E; Ramsoebhag A; Hop A; Persijn G; Laufer G
    Clin Transpl; 2003; ():89-100. PubMed ID: 15387100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA types in American black juvenile diabetics strong associations with Dw3 and Dw4.
    MacDonald MJ; Traisman HS; Levitsky LL; Duquesnoy RJ; Mullins P; Hackbarth SA
    Metabolism; 1981 Jun; 30(6):533-6. PubMed ID: 6453266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MLC (HLA-D) typing: a family study.
    Jørgensen F; Kristensen T; Lamm LU; Kissmeyer-Nielsen F
    Tissue Antigens; 1977 Nov; 10(5):379-93. PubMed ID: 75583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population studies of HLA-linked SB antigens and their relative importance in primary MLC typing. Analysis of HLA-D homozygous typing cells and normal heterozygous populations.
    Pawelec G; Shaw S; Schneider M; Blaurock M; Frauer M; Brackertz D; Wernet P
    Hum Immunol; 1982 Nov; 5(3):215-23. PubMed ID: 6217174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-HLA-D determinants detected by the micro-MLC test.
    Fainboim L; Festenstein H
    Transplant Proc; 1979 Mar; 11(1):700-3. PubMed ID: 88097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specificity of the inhibitory effect of a grand-multipara serum on MLC reactions and on responses to PHA, PWM and PPD.
    Herva E; Ilonen J
    Acta Pathol Microbiol Scand C; 1977 Dec; 85C(6):424-34. PubMed ID: 75658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Confounding factors in HLA-DW 2 typing of human leucocytes.
    Källén B; Löw B; Nilsson O
    Clin Exp Immunol; 1977 Jan; 27(1):55-62. PubMed ID: 139221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic analysis of patients with chronic active hepatitis.
    Page AR; Sharp HL; Greenberg LJ; Yunis EJ
    J Clin Invest; 1975 Sep; 56(3):530-5. PubMed ID: 125763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of matching for SB on MLC typing is significant but marginal.
    Termijtelen A; Naipal-van den Berge S; Suwandi-Thung L; van Rood JJ
    Scand J Immunol; 1984 Mar; 19(3):265-8. PubMed ID: 6231717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of HLA--D associated B lymphocyte (Ia-like) antigens in the cell membrane.
    Albrechtsen D; Solheim BG; Thorsby E
    Tissue Antigens; 1978 Apr; 11(4):372-83. PubMed ID: 78538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation between HLA-DW and the b-lymphocyte specificities.
    Park MS; Terasaki PI; Saito S; Opelz G
    Scand J Immunol; 1977; 6(5):413-8. PubMed ID: 70058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA antigens in Hodgkin's disease of very long survival.
    Hornmark-Stenstam B; Landberg T; Löw B
    Acta Radiol Oncol Radiat Phys Biol; 1978; 17(4):283-8. PubMed ID: 717041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.